Theranos: timeline, technology, fraud, money
- SEC: Theranos, CEO Holmes and former president Balwani charged with massive fraud (2018)
- SEC litigation release 24069
- CNBC: Holmes and Balwani charged with massive fraud
- MedCity News: Holmes gives up control in SEC settlement
- Refinery29: What the Edison was supposed to do
- Fierce Biotech: Holmes admits to using altered Siemens analyzers
- Time: Theranos under fire in the Wall Street Journal report
- CBC: Carreyrou on the rise and fall of Theranos
- US v. Holmes trial exhibit 13769 (Edison protocol email)
- US v. Holmes trial exhibit 10691 (patent list)
- Google Patents: US 7,291,497, analyte monitoring and drug delivery
- The Drey Dossier: the 2003 provisional patent
- University of Arkansas thesis on Theranos (TheraPatch and Phyllis Gardner)
- TechCrunch: Theranos voids two years of Edison results
- Fierce Biotech: Theranos trashes two years of results
- HC Innovation Group: CMS imposes sanctions
- CBS San Francisco: Theranos voids Edison results
- BioSpace: Feds find serious deficiencies at Theranos lab
- JALM: the Theranos session at AACC 2016
- Dark Daily: AACC presentation failed to convince
- KQED: Theranos presentation mostly a dud
- MLO: Theranos makes its case at AACC
- Theranos press release on the miniLab (2016)
- Fierce Biotech: Walgreens sues Theranos for $140M
- Fierce Biotech: tentative Walgreens settlement
- Fierce Biotech: Theranos and Walgreens settle
- MedTech Dive: Walgreens pays $44M to settle customer claims
- Quartz: how Safeway and Walgreens fell for Theranos
- MedCity News: three twists in the Theranos saga (2017)
- IAM: Fortress royalty-free COVID licenses after the BioFire suit
- 360Dx: BioFire sued over Theranos patents
- Patent Progress: patents in the time of coronavirus
- Harvard Petrie-Flom: patent fakes and fraud
- CBS: Holmes's sentence reduced
- Forbes: Holmes to a halfway house in 2027
- Axios: what's next for Holmes (October 2026)
- LA Mag: release date moved up
- Legal United States: release date and clemency status
- Background: Wikipedia articles on Theranos and Elizabeth Holmes, and John Carreyrou's book Bad Blood (2018).
Haemanthus and Raman spectroscopy
- Fortune: Haemanthus has patents, investors and a missing CTO but no product (October 2026)
- Wikipedia: Haemanthus (company)
- PharmaVoice: a startup with Theranos ties, and the competition waiting
- Forbes: Billy Evans's employment history
- Yahoo Finance: "This is not Theranos 2.0"
- Advanced Photonics Research (2025): Raman spectroscopy in clinical medicine
- Clinical Chemistry and Laboratory Medicine (2026): critical assessment of Raman diagnostics
- Biophysical Reviews (2025): SERS troponin assays
- PMC: portable SERS for whole-blood monitoring
- arXiv: optofluidic Raman glucose quantification
Capillary versus venous blood
- AJCP (2021): preanalytical challenges of fingerstick sampling in inpatients
- CCLM (2024): capillary versus venous for 34 chemistry analytes
- JALM: upper-arm capillary device versus venous and fingerstick
- PMC (2025): capillary point-of-care WBC and CRP in pediatrics
- Renal and Urology News: plasma potassium self-monitoring
- Lola Health: finger prick versus venous (hemolysis rates)
- Medscape (2026): what Theranos's legacy teaches
Narrow-menu devices shipping for decades
- Abbott i-STAT cartridge menu (McKesson PDF)
- Abbott i-STAT cartridge and test information
- CLIA-waived tests for the i-STAT system
- CAP Today 2025 low-volume chemistry and immunoassay analyzer guide
- Imants Lauks profile and Lexology on Abbott v. Epocal
- Abbott Piccolo Xpress, Abaxis products, Piccolo electrolyte panel insert
- Wikipedia: Abaxis, Abaxis 8-K on the Zoetis merger, Today's Veterinary Business: Zoetis closes Abaxis
- Abbott Cholestech LDX lipid profile cassette and CLIAwaived listing
- Quest acquires HemoCue (2007), GenomeWeb: Quest sells HemoCue to Radiometer
- Acta Paediatrica: HemoCue WBC DIFF evaluation, PubMed: HemoCue WBC DIFF for clozapine monitoring
- McKesson: Siemens DCA Vantage, Abbott Afinion 2, STAT Technologies: Afinion 2 pricing
- Roche cobas b 101, DocCheck Shop pricing
- Aidian QuikRead go, Aidian company brochure, CureMed Nordic pricing
- Eurolyser CUBE-S
- HORIBA Microsemi CRP LC-767G, Careggi NICU study, Japanese evaluation
- Sysmex pocH-100i, JALM: XW-100, the first CLIA-waived CBC, ADLM: Sysmex CBC receives CLIA waiver
- Supermarket News: Kroger rolls out blood testing devices, BioSpace: Kroger Health and PTS Diagnostics
- PMC: StatStrip cleared for critically ill patients, PMC: StatSensor creatinine evaluation
- Boditech Q2 2025 results, Seoul Economic Daily: Boditech Q2 2026, Boditech LinkedIn (installed base)
- Wondfo Finecare platform, Getein 1100
- Fujifilm DRI-CHEM NX10N, Clinical Chemistry abstract on the NX700i, Arkray SpotChem EZ
Multi-category instruments
- Truvian: FDA clearance for TruVerus, Medtech Insight: launch in H2 2026, MassDevice: Truvian and Siemens Healthineers, San Diego Business Journal, Tracxn funding, PitchBook
- 360Dx: Genalyte TSH 510(k), Clinical Chemistry abstract A-380, Genalyte at ADLM 2025, FDA K191085, PMC: Maverick serology evaluation
- biosurfit company history, FIND immunoassay platform landscape (2025), spinit CRP at MEDICA 2025, MTEC profile
- PMC: LABGEO PT10 evaluation, Samsung discontinuation notice
- Roche closes the LumiraDx acquisition, MedTech Dive: Roche to buy LumiraDx technology, LumiraDx Form D filings, PitchBook: LumiraDx, Wikipedia: Ron Zwanziger
- Baebies: dual 510(k) and CLIA waiver for flu and COVID PCR, Baebies: anti-Xa Breakthrough designation, Baebies: G6PD 510(k)
- 360Dx: bioMérieux acquires SpinChip, Pathology in Practice: SPINCHIP launch
- Siemens Healthineers: Atellica VTLi, PLAyEUS trial methods, VTLi clinical evidence
- Wikipedia: Abionic, ADLM: Abionic CE marks
- Nanomix whole-blood CE mark, 360Dx: Nanomix commercial plans
- ProciseDx: FDA clearance of instrument and CRP, FDA K201256, Fierce Biotech: 5-minute drug-level tests
- OPKO: Sangia PSA approval, FDA PMA P170037 summary, Phys.org: mChip
Hematology from a drop
- Fierce Biotech: Sight OLO cleared, PMC: OLO clinical study, MassDevice: Sight's waiver plans, McKesson: OLO non-waived, CNBC Disruptor 50, Calcalist: 30% layoff, Calcalist: all employees laid off
- FDA K180020 decision summary, FDA K222148 (direct capillary), CAP Today: HemoScreen direct capillary, CLIAwaived: HemoScreen pricing
- FDA K181288 (Athelas One), FDA K200828 (Athelas Home), Athelas point-of-care clearance (2026)
- 360Dx: Essenlix, Essenlix iMOST-U, ClinicalTrials.gov NCT04778553
- HT World: Entia Liberty approved in the UK, HLTH: Careology and Entia
- Sanguina AnemoCheck Home clearance
Home devices and kiosks
- Intel Capital: SiPhox raises $27M, LongeVC: SiPhox A2 round
- Bloom Lab, Startupticker: Bloom store in Zurich
- The Engineer: Kalium Health, PMC: point-of-care potassium review
- North Data: 1Drop SA register entries, Tracxn: 1Drop
- STAT: Cue Health lays off all employees, Fierce Biotech: Cue shuts down, MassDevice: FDA revokes Cue EUA, Ideaproof: Cue post-mortem
- Tech Startups: Forward shuts down, Forward post-mortem
- Crunchbase: Flux Bioscience (closed), BioSpace: Tyler Shultz's company, Wikipedia: Tyler Shultz
Collection plus central lab
- MD+DI: Babson in 2026, BetterWay, CLP: BetterWay expands menu, Medical Device Network: BD and Babson expand, Babson press page reprint, Warp News, Tracxn: Babson funding
- CAP Today: FDA clears BD MiniDraw, MassDevice: BD MiniDraw, MedTech Dive: BD clearance
- FDA K221131 (Tasso+), Tasso FAQ, Tasso+
- Medical Device Network: YourBio clearance, FDA K161521 (TAP)
- Drawbridge OneDraw A1C clearance, Thorne acquires majority of Drawbridge
- Vitestro CE mark, Vitestro raises $70M, Aletta
Consumer lab services
- Wikipedia: Function Health, Fierce Healthcare: Function Series B, Radiology Business: Function acquires Ezra, New Market Pitch: is Function worth $2.5B
- New Market Pitch: at-home blood test companies ranked
- Quest Q3 2026 8-K, Quest FY2025 10-K
- LabCorp and Walgreens: at least 600 centers
- Startuply: Thriva reaches 650,000 tests, CB Insights: LetsGetChecked, Tracxn: Everly Health
Molecular point of care
- Visby: first OTC PCR De Novo, Visby flu and COVID OTC clearance
- binx io, Sapphiros and binx merge into Onvaro
- Motilal Oswal report on Molbio (2026), Lattice industry report (2025), Modern Ghana: Kochon Prize
Continuous monitoring (the 2003 vision)
- Abbott: Libre Duo dual glucose-ketone authorization (August 2026)
- HCPLive: Biolinq De Novo, Drug Delivery Business: Biolinq, Biolinq
- C&EN: drug monitoring with a DNA-based microneedle sensor, MPO: Nutromics Breakthrough designation, BioMelbourne: first-in-human trial, a skeptical view
Low-resource and academic work
- HealthCube public health deployments, Acumen: HealthCube, PMC (2025): point-of-care devices in Indian primary care
- SigTuple AI100, NITI Aayog: SigTuple
- Hemex Gazelle Breakthrough designation, PMC: Gazelle for knowlesi malaria, Gazelle at ASH 2024
- DOB Equity: Ilara Health, Butterfly Network: Ilara Health
- PMC: lens-less flow cytometer on a chip, arXiv: open-source lensless holographic platform, PMC: machine-learning lens-free cytometry
Retail health
- STAT: Walmart Health closing 51 centers, Walmart: Walmart Health is closing, Fortune: why Walmart Health closed
- Walgreens 10-Q (VillageMD impairment), Healthcare Dive: Walgreens and Sycamore
Market, reimbursement and sites
- MarketsandMarkets: US point-of-care diagnostics, Polaris, Nova One Advisor
- Grand View Research: US clinical lab tests, Arizton, Global Market Insights (14 billion tests, 266,000 labs)
- CMS Clinical Laboratory Fee Schedule, Kentucky 2026 rates (mirrors Medicare), Discoveries in Health Policy: 2026 CLFS, CMS MLN MM14312
- NCPA 2025 Digest, ScrapeHero: largest pharmacies, xMap: Walmart pharmacies
- Urgent Care Association data, JUCM: top 100 urgent care operators
- BLS: phlebotomists
- ScienceDirect: community pharmacies as CLIA-waived facilities, ADLM: CLIA certificate of waiver sites, PMC: state variation in pharmacy waived testing
- Your Care Coalition: pharmacist test-and-treat tracker, North Carolina SB 414, Drug Topics: 2025 pharmacy legislation, NCPA point-of-care testing guide
Regulation
- FDA Law Blog: court vacates the LDT rule, Federal Register: implementation of the vacatur (September 19, 2025)
- FDA: CLIA Waiver by Application, FDA guidance: dual 510(k) and CLIA waiver studies, Pure Global: 510(k) review clocks and dual-track timing, MedDevice Guide: waiver strategy
- Westgard: CLIA acceptance limits in force from 2025, Bio-Rad: CLIA 2024 limits
- McDermott: CMS updates lab personnel requirements, QBench: CLIA certification guide, ScienceInsights: getting a CLIA number
- Referenced without links: FDA's Quality Management System Regulation (effective February 2, 2026), section 524B of the Federal Food, Drug, and Cosmetic Act, FDA's guidance on predetermined change control plans for AI-enabled device software, SEC Rule 21F-17, 42 CFR 493 (CLIA), 21 CFR 862.1675, Washington's My Health My Data Act, and CLSI documents EP05, EP06, EP07, EP09, EP15, EP17, EP25, EP28 and GP42.
Bench starter
- HunStat2 on GitHub and paper (Analytical Methods, 2025), HELPStat (ACS Electrochemistry), FreiStat for AD5940/AD5941
- IO Rodeo: Zimmer and Peacock 501 carbon electrodes, ZP glucose sensors and Sensit Smart, ZP buy-and-try pricing
- OpenFlexure blood imaging autofocus (arXiv), Robotic microscopy for everyone (bioRxiv), OpenFlexure_Cell_Counter, Mini-hematology-lab, OpenFlexure malaria study
- OpenDrop digital microfluidics
- Bioengineering (2025): paper glucose with plasma separation and a smartphone, Sensors (2024): label-printer paper device, Pall Vivid plasma separation datasheet, Analytica Chimica Acta (2025): dual-gradient membranes, PMC: 3D-printed plasma separation
- Microsystems and Nanoengineering (2025): low-cost optical sensors in lab-on-a-disc, PLOS ONE (2022): open-source 3D-printed centrifuge adaptor, PMC: lab-on-a-disc separation with gel
- Microsystems and Nanoengineering (2024): impedance cytometry leukocyte differential, Biosensors (2025): electrical blood counts review
- Zander R, Lang W, Wolf HU. Alkaline haematin D-575, a new tool for the determination of haemoglobin as an alternative to the cyanhaemiglobin method. Clinica Chimica Acta, 1984.
One drop, many tests
- Fortune (June 2014): the Theranos cover story, Fortune (December 2015): "How Theranos misled me", Smithsonian (March 2014): 30 tests on a single drop
- SEC complaint against Theranos and Holmes (PDF), SEC complaint against Balwani (PDF)
- Google Patents: Modular point-of-care devices (Theranos), Google Patents: US 7,635,594 point-of-care fluidic systems, USPTO: Systems and methods for sample use maximization, Justia: patents assigned to Theranos
- Nightingale Health technology, UK Biobank NMR companion document, Nature Communications (2023): atlas of plasma NMR biomarkers in 118,461 people, Nightingale: half a million UK Biobank metabolomes, Nightingale consumer service in Finland, Nightingale Home at Yliopiston Apteekki
- CDC MMWR (2001): tandem mass spectrometry in newborn screening, Clinical Chemistry (2001): New England program, 23 disorders, NEJM (2003): screening newborns for 31 disorders by tandem MS, APEM review of expanded newborn screening
- SomaLogic: 7,000 proteins from 55 µL, SomaLogic platform, Olink Explore HT, bioRxiv (2025): technical evaluation of plasma proteomics technologies, Alamar NULISA dried blood spot kit (June 2026), Alzforum: a finger-prick test for Alzheimer's
- Thermo Fisher: Luminex xMAP INTELLIFLEX, R&D Systems: what is a Luminex assay, Randox Biochip Array Technology, Randox RABTA brochure (2025)
- Trends in Biotechnology: multiplexed point-of-care testing (xPOCT), Nature Communications (2025): machine learning in point-of-care testing
- Dxcover trials, SLAS Technology (2025): ATR-FTIR serum lung cancer study
- Journal of Chromatography B (2026): portable mass spectrometry for point-of-care testing, Analytical and Bioanalytical Chemistry (2025): miniature mass spectrometer assay for psychiatric drugs